Honeybee Trials is a healthcare startup founded in 2019 and based in Canada. The company’s slogan, “Helping researchers recruit clinical trial patients at scale,” encapsulates its mission to address the challenges of patient enrollment in clinical trials. With a focus on improving clinical trial recruitment, the platform aims to combat the delayed and terminated trials which historically plague the industry. The disparity in clinical data representation is a key issue the company is addressing. Honeybee Trials recognizes that 99.99% of the global population is underrepresented in clinical research, underscoring the demand for greater diversity and higher participation rates in trials. The company has attracted investment from gbeta in the form of non-equity assistance. This investment, received on 01 September 2019, demonstrates confidence in the potential impact of the company's data-driven software in revolutionizing the patient journey through clinical trials. Honeybee Trials is developing software to transform how patients discover, enroll, onboard, and participate in clinical trials. By driving higher participation rates, greater diversity, and lower attrition, the startup aims to expedite the delivery of health products and services to the market. Honeybee Trials represents a promising opportunity for investment in the healthcare sector, with its innovative approach to tackling critical challenges in clinical trial patient recruitment.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Non Equity Assistance | Unknown | 1 | gbeta | 01 Sep 2019 |
No recent news or press coverage available for Honeybee Trials.